Public filing of Form F-4 represents important milestone in transaction towards Xanadu becoming first and only publicly ...
This filing follows Pubco's confidential submission of a draft registration statement on Form S-4, as previously announced on November 13, 2025, and reflects ongoing progress in the SEC review process ...
Quadruplet regimen demonstrated significantly deeper and more durable responses, higher MRD negativity and improved progression-free survival versus a standard of care?